SIG
MRNA icon

Sargent Investment Group’s Moderna MRNA Stock Holding History

Sargent Investment Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,250
Closed -$317K – 197
2021
Q4 		$317K Sell
1,250
-20
-2% -$5.85K 0.07% 148
2021
Q3 		$489K Sell
1,270
-80
-6% -$29.5K 0.12% 118
2021
Q2 		$317K Buy
+1,350
New +$241K 0.08% 156

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sargent Investment Group's MRNA Position: Q1 2022 in Review

Sargent Investment Group sold out of Moderna (MRNA) in Q1 2022, closing a stake of 1,250 shares — an estimated $317K sold.

Sargent Investment Group first reported a position in MRNA in Q2 2021 and held it in 3 quarters. The position peaked at $489K in Q3 2021. 1,006 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • Sargent Investment Group reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • Sargent Investment Group sold 1,250 Moderna shares in Q1 2022, an estimated $317K.
  • Sargent Investment Group first reported a position in Moderna in Q2 2021 and held it in 3 quarters.
  • Sargent Investment Group's Moderna position peaked at $489K in Q3 2021.
  • 1,006 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on Sargent Investment Group's 13F filing for Q1 2022, filed 6 May 2022.